F Theves (F Thèves)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Dikelele Elessa, V Grosjean, P Lozeron, S Harel, B Royer, N Forgeard, F Theves, A Talbot, Marion Malphettes, D Bengoufa, N Kubis, Bertrand Arnulf
Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases. British journal of haematology (2024)
Dikelele Elessa, V Grosjean, P Lozeron, S Harel, B Royer, N Forgeard, F Theves, A Talbot, Marion Malphettes, D Bengoufa, N Kubis, Bertrand Arnulf
Rituximab with alkylating agent in anti-myelin-associated glycoprotein neuropathy: A retrospective study of 26 cases. British journal of haematology 204 (6) (2024)
F Theves, C Lahuna, Thibault Mahevas, S Harel, B Royer, V Lemiale, A Brignier, N Parquet, Marie Jachiet, Jean-David Bouaziz, D Elessa, B Arnulf, Alexis Talbot
Plasma cell-directed therapies induce profound clinical and durable responses in patients with severe or relapsed/refractory scleromyxedema. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)